News

Traditionally, HTA or health technology assessment is usually conducted to help inform government’s coverage and reimbursement decisions, or pricing negotiations after the technology has become available in the market or received FDA approval

Health innovations advanced with ‘Early Health Technology Assessment’

As the COVID-19 pandemic continues to unfold, it has become increasingly accepted that day-to-day life will not return to anything close to normality until a vaccine or effective treatment is available and widely accessible.

Based on a real-world collaboration with innovators in applying early health economic modeling, we aimed to offer practical steps that health technology assessment (HTA) researchers and innovators can follow and promote the usage of early HTA among research and development (R&D) communities.